Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Since my diagnosis, my mission has been to fight back

    ... setbacks that kept me in isolation longer than expected. A blood infection (sepsis) sent me to the ICU for three days. I watched the days ... completed my 34th cycle of azacitidine and have not needed a transfusion in over 2 1/2 years. It has now been four years since my relapse, ...

    Patient Chronicle last updated 04/26/2018 - 10:40am.

  2. MDS - Treatment (OLD)

    ... mature Increase the number of healthy cells in your blood Kill abnormal bone marrow cells  Reduce the number of blasts ... infection Blood Transfusions A blood transfusion is a safe and common procedure. When you receive a transfusion, ...

    Topic section last updated 07/20/2018 - 5:15pm.

  3. ASCO Updates Platelet Transfusion Guideline Prophylaxis unnecessary for adults undergoing HSCT

    ... infusion, according to an updated guideline for platelet transfusion in patients with cancer. The recommendation, which applies ... in 2015 by the AABB (formerly the American Association of Blood Banks) and the International Collaboration for Transfusion Medicine ...

    Research Article last updated 12/06/2017 - 11:23am.

  4. Ron Carlsen Beats Early Onset MDS; Grapples with Post-Transplant GVHD

    ... started to bruise easily with no explanation, and my red blood cell count started to drop. Eventually, I was put on epoetin alfa ... lenalidomide. By October 2006, I had become blood transfusion dependent, requiring one each week. The new problem was my ...

    Patient Chronicle last updated 07/19/2018 - 2:41pm.

  5. Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence

    ... resulting in refractory cytopenias. Red blood cell (RBC) transfusions can improve anemia ; however, prolonged transfusion dependence (TD) is associated with increased morbidity and ...

    Research Article last updated 09/13/2017 - 8:58am.

  6. Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

    ... chronic myelomonocytic leukaemia ( white blood cell count <13 000/μL), and had anaemia with or without red blood cell transfusion support. Enrolled patients were classified as having low ...

    Research Article last updated 09/18/2017 - 1:38pm.

  7. Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors

    ... of life, as well as iron overload due to red blood cell transfusion support. To promote proliferation and differentiation of ...

    Research Article last updated 10/23/2017 - 11:08am.

  8. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... to lenalidomide for the treatment of red blood cell transfusion -dependent anemia . Although lenalidomide has ...

    Research Article last updated 10/23/2017 - 10:58am.

  9. Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors

    ... of life, as well as iron overload due to red blood cell transfusion support. To promote proliferation and differentiation of ...

    Research Article last updated 10/02/2017 - 10:10am.

  10. Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond

    ... to lenalidomide for the treatment of red blood cell transfusion -dependent anemia . Although lenalidomide has ...

    Research Article last updated 10/02/2017 - 9:54am.